Home › Merck Signs Sale Agreement with Santen for Mercks Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific
 

Keywords :   


Merck Signs Sale Agreement with Santen for Mercks Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific

2014-05-13 08:15:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it signed an agreement for Santen Pharmaceutical Co., Ltd. Language: English Contact: MerckMedia:Caroline Lappetito, 267-218-1584orMamoru Ohara, 81-3-6272-1001orInvestor:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: products key sale japan

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11Portrait.Of.Pirates ver2.5
24.11Switch
24.11 / TIN
24.11duranduranALMGHTY 26.5cm
24.11straykids skzoo
24.11 4
24.11 TrioTryiT Figure21
24.11
More »